Replies to post #401427 on NorthWest Biotherapeutics Inc (NWBO)

[DavidW2]

Believe me I won't thank you

unless something huge really happen on 10/9. I hope it is good news, not bad news though.

[biosectinvestor]

We’re going to have to change how things are done here if you’re right. Along with stock charts, Sojo is going to have to post your astrological charts so we can see what is next with NWBO.

[ae kusterer]

Ike Esq.: Here's one.What, please, are the others?





12:45–4:15 pm SYM20B: Immunotherapy for Brain Tumors: New Concepts Course Directors: E. Antonio Chiocca, Linda M. Liau Faculty: Nduka M. Amankulor, William T. Curry, Peter E. Fecci, Amy B. Heimberger, Michael Lim, Edjah K. Nduom, Hideho Okada, Ian F. Parney Course Description: This symposium will provide a brief overview of relevant immunological principles and define discrete immune pathways regulating the initiation and progression of malignant brain tumors. More importantly, cutting-edge immunotherapeutic approaches for the treatment of CNS tumors will be defined. Learning Objectives: ? Evaluate various immune pathways that contribute to the formation and progression of CNS malignancies ? Compare different immunotherapeutic strategies, including virotherapy, adoptive cellular immunotherapy, and immune checkpoint inhibition ? Compare neoadjuvant and adjuvant immunotherapy strategies





https://2021meeting.cns.org/Assets/edccc356-3f88-4c09-ba3f-b101e0a28585/637636915731000000/cns21787-21am-prelim-05242021-copy-with-4-new-gss-pages-080421-3-pm-pdf?inline=ture



IkeEsq Saturday, 09/11/21 10:29:12 PM
Re: DavidW2 post# 401424 0
Post #
401427
of 401464
This board talks about lots of things. Doesn't make them true.

The answer to your question, however, is October 9, 2021. 'Why?' you ask? Because I have 5 other, totally unrelated to each other or to NWBO things that are all now happening around October 9, so clearly the universe is speaking or something. No need to thank me.